Results 31 to 40 of about 9,805,880 (332)

Epidemiology of biopsy‐proven glomerular diseases in Chinese children: A scoping review

Chronic Diseases and Translational Medicine, 2022
Background Glomerular disease is the leading cause of chronic kidney disease globally. No scoping review reports have focused on China's spectrum of glomerular diseases in children.
Yetong Li, Yue Yang, Li Zhuo, Dan Wu, Wenge Li, Xiaorong Liu   +5 more
doaj   +1 more source

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.

American Journal of Kidney Diseases, 2019
RATIONALE & OBJECTIVES Glomerular diseases, including minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and immunoglobulin A (IgA) nephropathy, share clinical presentations, yet result from multiple biological mechanisms.
L. Mariani, A. Bomback, P. Canetta, Michael F. Flessner, M. Helmuth, M. Hladunewich, J. Hogan, Krzysztof Kiryluk, P. Nachman, Cynthia C. Nast, M. Rheault, Dana V. Rizk, H. Trachtman, Scott E. Wenderfer, Corinna Bowers, Peg Hill-Callahan, M. Marasà, Caroline Poulton, Adelaide Revell, S. Vento, L. Barisoni, Daniel C. Cattran, Vivette D. D'Agati, J. C. Jennette, Jon B. Klein, L. Laurin, K. Twombley, R. Falk, A. Gharavi, B. Gillespie, D. Gipson, Larry A. Greenbaum, L. Holzman, M. Kretzler, Bruce M. Robinson, W. Smoyer, L. Guay-Woodford, Wooin Ahn, Gerald B. Appel, Revekka Babayev, Ibrahim Batal, Eric R. Brown, E. Campenot, P. Canetta, Lucrezia Carlassara, Brenda Chan, Debanjana Chatterjee, Vivette D. D'Agati, Elisa Delbarba, Samriti Dogra, Hilda E. Fernandez, B. Foroncewicz, G. Ghiggeri, William H. Hines, S. Ali Husain, N. Jain, P. Khairallah, B. H. Kil, A. Jeyabalan, W. L. Lau, Fangming Lin, Francesca Lugani, G. Markowitz, S. Mohan, Xueru Mu, K. Mucha, T. Nickolas, Stacy E. Piva, J. Radhakrishnan, Maya K. Rao, Renu Regunathan-Shenk, S. Sanna-Cherchi, D. Santoriello, Shayan Shirazian, M. Barry Stokes, N. Yu, Anthony M. Valeri, Ronald Zviti, A. Al-Uzri, Josephine M. Ambruzs, I. Ashoor, D. Aviles, Rossana Baracco, J. Barcia, Sharon M. Bartosh, C. Belsha, Michael C. Braun, Yi Cai, V. Chernitskiy, A. Chishti, D. Claes, Kira Clark, Carl H. Cramer, Keefe Davis, Amy Dutcher, E. Erkan, D. Feig, M. Freundlich, J. Gaut, R. Gbadegesin, Melisha G. Hanna, G. Hidalgo, D. Hooper, T. Hunley, Amrish Jain, M. Kallash, M. Kamel, Myda Khalid, T. Kump, J. Lane, H. Liapis, J. Mahan, N. Mathews, C. Nester, C. Pan, Larry T. Patterson, H. Patel, A. Raad, Cynthia Silva, Rajasree Sreedharan, T. Srivastava, J. Steinke, Susan Sumner, Tetyana L Vasylyeva, Chia-shi Wang, Donald J. Weaver, Craig S. Wong, H. Yin, Anand Achanti, S. Almaani, I. Ayoub, M. Budisavljevic, Maggie D’Angelo, V. Derebail, Huma Fatima, R. Falk, A. Fogo, K. Gibson, Dorey A. Glenn, S. Hogan, K. Jain, B. Julian, J. Kidd, H. D. Massey, A. Mottl, Shannon Murphy, T. Nadasdy, J. Novak, Samir M. Parikh, Caroline Poulton, T. B. Powell, B. Reeve, M. Renfrow, M. Reynolds, Dana V. Rizk, B. Rovin, Virginie Royal, M. Saha, Neil S. Sanghani, S. Self, S. Adler, N. Alachkar, C. Alpers, Raed Bou Matar, C. Avila-Casado, S. Bagnasco, Emily Brede, Elizabeth Brown, Daniel C. Cattran, M. Choi, G. Contreras, K. Dell, D. DeWalt, M. Denburg, R. Dukkipati, F. Fervenza, A. Fornoni, C. Gadegbeku, P. Gipson, Anny Gonzalez-Zea, Leah Hasely, Elizabeth M. Hendren, S. Hingorani, M. Hladunewich, J. Hogan, Jean Hou, J. A. Jefferson, K. Jhaveri, D. Johnstone, F. Kaskel, A. Kogan, J. Kopp, R. Lafayette, K. Lemley, L. Malaga-Dieguez, K. Meyers, A. Neu, M. O'shaughnessy, John F. O'Toole, A. Oliverio, Matthew Palmer, R. Parekh, Renée A. Pitter, H. Reich, Kimberly J. Reidy, Helbert Rondon, K. Sambandam, M. Sampson, J. Sedor, D. Selewski, C. Sethna, J. Schelling, J. Sperati, Agnes Swiatecka-Urban, K. Tuttle, M. Waldman, J. Weisstuch, R. Wiggins, David S. Williams, C. Winkler, E. Young, O. Zhdanova, Charlotte A. Beil, R. Eikstadt, B. Gillespie, J. Graff, S. Hewitt, Emily G Herreshoff, Chrysta Lienczewski, Sarah A. Mansfield, L. Mariani, K. McCullough, Nicholas Moore, Bruce M. Robinson, Melissa Sexton, J. Troost, Matthew Wladkowski, J. Zee, D. Zinsser   +238 more
semanticscholar   +1 more source

Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China

Renal Failure, 2019
Background: To investigate the pathological spectrum of glomerular disease in patients with renal insufficiency (RI) from 2008 to 2017. Methods and results: We calculated the estimated glomerular filtration rate (eGFR) with the Chronic Kidney Disease ...
Liangmei Chen, Manyu Luo, Changqing Dong, Bing Li, Weiguang Zhang, Ping Nie, Juan Liu, Xiangmei Chen, Ping Luo   +8 more
doaj   +1 more source

Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome

Kidney International Reports, 2018
Treatment-resistant nephrotic syndrome is a rare form of glomerular disease that occurs in children and adults. No Food and Drug Administration−approved treatments consistently achieve remission of proteinuria and preservation of kidney function.
Howard Trachtman, Debbie S. Gipson, Michael Somers, Cathie Spino, Sharon Adler, Lawrence Holzman, Jeffrey B. Kopp, John Sedor, Sandra Overfield, Ayanbola Elegbe, Michael Maldonado, Anna Greka   +11 more
doaj   +1 more source

The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis

Frontiers in Immunology, 2021
ObjectiveTo characterize the incidence, type, and risk factors of severe infections (SI) in patients with autoimmune kidney diseases treated with rituximab (RTX).MethodsWe conducted a multicenter retrospective cohort study of adult patients with immune ...
Balazs Odler, Martin Windpessl, Martin Windpessl, Marcell Krall, Maria Steiner, Regina Riedl, Carina Hebesberger, Martin Ursli, Emanuel Zitt, Karl Lhotta, Marlies Antlanger, Daniel Cejka, Philipp Gauckler, Martin Wiesholzer, Marcus Saemann, Alexander R. Rosenkranz, Kathrin Eller, Andreas Kronbichler, Andreas Kronbichler   +18 more
doaj   +1 more source

SGLT2 Inhibitors and the Diabetic Kidney [PDF]

, 2016
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease worldwide. Blood glucose and blood pressure control reduce the risk of developing this complication; however, once DN is established, it is only possible to slow progression ...
Busetto, Luca, Fioretto, Paola, Rossato, Marco, Vettor, Roberto, Zambon, Alberto   +4 more
core   +1 more source

Podocyte-specific deletion of miR-146a increases podocyte injury and diabetic kidney disease

Frontiers in Medicine, 2022
Diabetic glomerular injury is a major complication of diabetes mellitus and is the leading cause of end stage renal disease (ESRD). Healthy podocytes are essential for glomerular function and health.
Xiaobo Li, Ishwarya Venkatesh, Veronica Villanueva, Huiting Wei, Terese Geraghty, Anugraha Rajagopalan, Richard W. Helmuth, Mehmet M. Altintas, Hafeez M. Faridi, Vineet Gupta, Vineet Gupta   +10 more
doaj   +1 more source

Organoid single cell profiling identifies a transcriptional signature of glomerular disease.

JCI Insight, 2019
Podocyte injury is central to many forms of kidney disease, but transcriptional signatures reflecting podocyte injury and compensation mechanisms are challenging to analyze in vivo.
J. Harder, R. Menon, E. Otto, Jian Zhou, S. Eddy, Noel L. Wys, C. O'Connor, Jinghui Luo, V. Nair, C. Cebrián, J. Spence, M. Bitzer, O. Troyanskaya, J. Hodgin, R. Wiggins, Benjamin S. Freedman, M. Kretzler   +16 more
semanticscholar   +1 more source

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy. [PDF]

, 2019
Standard methods for detecting and monitoring of IgA nephropathy (IgAN) have conventionally required kidney biopsies or suffer from poor sensitivity and specificity.
Fervenza, Fernando C, Lafayette, Richard A, Sarwal, Minnie M, Sarwal, Reuben D, Yang, Joshua YC   +4 more
core   +1 more source

Factor B Inhibition with Iptacopan in Recurrent C3 Glomerulopathy Following Kidney Transplant: A Report of Two Cases

Kidney Medicine
C3 glomerulopathy is a rare disease caused by fluid phase dysregulation of the alternative complement pathway. Currently, treatment depends on clinical and histological severity and includes nephroprotection, unspecific immunosuppression, and terminal ...
Víctor J. Escudero-Saiz, Ángela Gonzalez, Adriana García-Herrera, Ana B. Larque, Andrew S. Bomback, Laura Morantes, Marta Martínez-Chillarón, Júlia Ollé, Elena Guillén, Marc Xipell, Alicia Molina-Andújar, Diana Rodríguez, Elena Cuadrado, Judit Cacho, Carolt Arana, Núria Esforzado, Carla Bastida, Esteban Poch, Fritz Diekman, David Cucchiari, Luis F. Quintana, Miquel Blasco   +21 more
doaj   +1 more source